Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) currently has a daily average trading volume of 106.83M but it saw 58028517 shares traded in last market. With a market cap of 43.92M USD, the company’s current market price of $0.23 came rising about 1.16 while comparing to the previous closing price of $0.23. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.48 and as low as $0.12. In the recent trading on the day, stock has struck highest price mark of $0.232 while lowest mark touched by it was $0.26.
Taking a look at 20-day trading activity of Tonix Pharmaceuticals Holding Corp (TNXP) gives us an average price of $0.3388, while its current price level is -98.12% below from 52-week high level whereas it is 99.15% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.2461 while that of 200 days or SMA-200 reads an average of $1.6078. A closer look into the stock’s movement over the week reveals that its volatility is standing at 12.88% during that period while stretching the period over a month that increases to 40.89%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 44.01 which implies that the stock is in neutral territory.
ROTH Capital upgraded its recommendation for the stock as a “Buy” from “Neutral” on April 18, 2019 while assigning a price target of $4. ROTH Capital issued its recommendations for the stock as it upgraded the price target for the stock is $6.
Over the week, TNXP’s stock price is moving -8.20% down while it is -2.29% when we observe its performance for the past one month. Year-to-date it is -28.74% down and over the past year, the stock is showing a downside performance of -97.63%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of -7.68 while estimate for next year EPS is -35.52. In next quarter, company is expected to be making quarterly sales of $4.1M as analysts are expecting the sales for current fiscal year at $12.8M and seeing the company making $15.62M in sales next year. Moreover, analysts are in estimates of $3.2M for current-quarter revenue.
Currently, Tonix Pharmaceuticals Holding Corp’s total number of outstanding shares is 186.89M with 0.17% of that held by the insiders while 0.23% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -169.47% and return on equity (ROE) at -138.69%. Stock’s beta reads 2.05. Stock has a price to book (P/B) ratio of 0.49 while price to sale or P/S ratio amounts to 3.89. Its return on asset (ROA) is -115.46% on average.
